Clinical Trials Directory

Trials / Completed

CompletedNCT04417569

A Proof of Concept Study of Serum Progesterone Levels for IVF/ICSI Following HCG Trigger for Oocyte Maturation

A Proof of Concept Study to Determine the Rise of Progesterone Levels After Human Chorionic Gonadotrophin (hCG) Trigger in Stimulated Cycles of IVF/ICSI

Status
Completed
Phase
Study type
Observational
Enrollment
10 (actual)
Sponsor
ART Fertility Clinics LLC · Academic / Other
Sex
Female
Age
18 Years – 42 Years
Healthy volunteers
Accepted

Summary

This study will determine the rise of progesterone levels after human chorionic gonadotrophin (hCG) trigger in stimulated cycles IVF/ICSI

Detailed description

Studies have suggested that controlled ovarian hyperstimulation adversely affects endometrial receptivity. In ovarian stimulation cycles with exogenous gonadotrophins there is an ongoing debate regarding the effect of a late follicular phase progesterone level on reproductive outcomes. It is not yet clarified if an elevated serum progesterone level in the late follicular phase is a symptom or cause of an adverse effect on reproductive outcomes. A new hypothesis is evolving and gaining momentum providing a novel explanation for the association between late follicular phase progesterone rise and reproductive outcome. It is proposed that exogenous FSH (Follicle-stimulating hormone) administration results in supraphysiological levels of FSH, which induce an abundance of LH (luteinizing hormone) receptors on granulosa cells causing the follicles to become hypersensitive to LH-like activity (ie hCG trigger). Based on this hypothesis, the focus should be placed on the hCG trigger rather than on the late follicular phase progesterone rise.

Conditions

Interventions

TypeNameDescription
DRUGhCGhuman chorionic gonadotropin
DIAGNOSTIC_TESTUltrasoundEndometrial thickness monitoring
OTHERBlood testProgesterone, Luteinizing Hormone, Estradiol

Timeline

Start date
2021-02-04
Primary completion
2021-05-26
Completion
2021-06-30
First posted
2020-06-04
Last updated
2022-02-18

Locations

1 site across 1 country: United Arab Emirates

Source: ClinicalTrials.gov record NCT04417569. Inclusion in this directory is not an endorsement.